Avodart is a new medicine made by GlaxoSmithKline containing the active ingredient Dutasteride. Avodart (Dutasteride ) was originally developed for treating prostate enlargement, a condition known as Benign Prostatic Hyperplasia (BPH) in men. In the US, it has passed Phase II testing for the treatment of hair loss in men but has formal approval as a prostate treatment medication only.

Avodart inhibits a hormone known as DHT (dihydrotestosterone). DHT is a hormone that appears to cause hair loss in most men. DHT is also the main cause of prostate enlargement in many men (also known as BPH - Benign Prostatic Hyperplasia). Avodart works by inhibiting the activities of two types of 5-alpha-reductase enzymes. These enzymes are responsible in the body for converting Testosterone to Dihydrotestosterone(DHT). Avodart lowers DHT levels substantially.

GlaxoSmithKline, the maker of Dutasteride, has completed Phase II trials for the FDA approval of Avodart (Dutasteride) as a treatment for hair loss. After six months of treatment, hair counts measured in a 1 inch diameter increased by about 96 hairs with 0.5mg of Avodart (Dutasteride). This is compared with an increase of only 72 hairs with the administration of 5mg Finasteride (Propecia).

Both medications work in a similar way, lowering DHT levels. However, Avodart inhibits the action of two types of 5-alpha-reductase enzymes (type I and type II). Propecia (Finasteride) only inhibits one type of the enzyme (type II). Avodart is more potent. Avodart has been shown to decrease levels of DHT by about 30% more than Propecia (Finasteride).

The MLN does prescribe Avodart (Dutasteride) and despatches it within 24 hours. But for your own protection, everyone applying online must be screened by our doctors. This is a quick, confidential process but it can allow for the delivery of your medication within 24 hours. It starts here.